ProPhase Labs, Inc. (PRPH)


Stock Price Forecast

April 23, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ProPhase Labs, Inc. chart...

About the Company

We do not have any company description for ProPhase Labs, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

53

Exchange

Nasdaq

$47M

Total Revenue

53

Employees

$93M

Market Capitalization

-6.54

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PRPH News

ProPhase Labs, Inc. (PRPH)

6d ago, source: Yahoo Finance

Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE ...

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript March 15, 2024 ProPhase Labs, Inc. misses on earnings ...

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

1d ago, source:

Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes ...

ProPhase Labs Unveils Project ZenQ-AI

8d ago, source:

Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates ...

Prophase Flat On Cancer Drug Progress

14d ago, source:

Monopar Shares Cheer Trial Results <li /> Boeing's Airplane Deliveries Plunge Amid Safety Review <li /> Delta Air Lines ...

ProPhase Labs Inc (PRPH) Stock: Analyzing the Market Value

7d ago, source: newsheater

The stock price of ProPhase Labs Inc (NASDAQ: PRPH) has jumped by 19.42 compared to previous close of 6.16. Despite this, the company has seen a gain of 20.49% in its stock price over the last five ...

ProPhase Labs, Inc.: ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

14d ago, source:

ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and diagnostics company, today reported its ...

ProPhase Labs Inc PRPH

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...